Glioblastoma is the most prevalent and aggressive brain tumor. It proliferates very rapidly, is highly invasive, and there is ...
1 AAU Energy, Aalborg University, Aalborg, Denmark 2 Center for Sustainable Energy Materials, Department of Chemistry, Aarhus University, Aarhus, Denmark The valorization of waste biomass into ...
Jan 13 (Reuters) - The U.S. Food and Drug Administration approved Fortress Biotech (FBIO.O), opens new tab and Indian drugmaker Zydus Lifesciences' (ZYDU.NS), opens new tab drug for children with a ...
Nuvation Bio shares dipped after the oncology company issued preliminary sales numbers for Ibtrozi behind Wall Street's expectations. Shares fell 16% to $6.77 late Monday morning. The stock has more ...
Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, today announced that the U.S. Food and Drug Administration (FDA) has ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Medical biotechnology company ...
Once approved, tegoprazan will be the first Potassium-Competitive Acid Blocker (P-CAB) to demonstrate superiority in EE healing across all severity grades (LA Grades A-D) and at all time points versus ...
Researchers from SAHMRI, SA Pathology and Adelaide University, have developed a new, highly targeted therapeutic approach that could improve outcomes for people living with myelofibrosis, a rare and ...